KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Q3 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Capital Employed rose 2300.0% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 0.01% for FY2024, which is 2000.0% up from last year.
  • Per Aurinia Pharmaceuticals' latest filing, its Return on Capital Employed stood at 0.16% for Q3 2025, which was up 2300.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Return on Capital Employed registered a high of 0.16% during Q3 2025, and its lowest value of 0.57% during Q3 2021.
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Capital Employed had a median value of 0.19% in 2023 and averaged 0.2%.
  • In the last 5 years, Aurinia Pharmaceuticals' Return on Capital Employed plummeted by -2000bps in 2021 and then skyrocketed by 3100bps in 2022.
  • Aurinia Pharmaceuticals' Return on Capital Employed (Quarter) stood at 0.44% in 2021, then skyrocketed by 42bps to 0.26% in 2022, then increased by 25bps to 0.19% in 2023, then skyrocketed by 95bps to 0.01% in 2024, then skyrocketed by 1639bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.12% for Q2 2025, and 0.07% during Q1 2025.